Analysis of Deals in Neurodegenerative Diseases

PharmaDeals, July 2010, Pages: 105

This essential report will help you to identify key trends and who your prospective partners are within the area of neurodegenerative diseases.

This new report follows the highly acclaimed and popular report series on key deal making therapy areas. It focuses on the five major neurodegenerative diseases:

- Alzheimer’s disease
- Parkinson’s disease
- Multiple sclerosis
- Epilepsy
- Migraine

The report contains analysis of deals by deal and product type, number of deals year on year and the value and stage of development of these deals. It looks at the key players and includes case studies of the key deals being made within the five neurodegenerative diseases.

** To view the reports full table of contents, please see the sample below

Product Samples

A sample for this product is available. Please Login/Register to download this sample.

Customers who bought this item also bought

• 08 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities
• Nitric Oxide - Therapeutics, Markets and Companies
• Molecular Biology of Neurodegenerative Diseases, Vol 107
• Dealmaking and Industry Outlook: Neurological Disease
• Neurodegeneration. The Molecular Pathology of Dementia and Movement Disorders. 2nd Edition
• Key Findings from Treatment Algorithms: Parkinson's Disease
• Stem Cell Approaches in Neurology and Psychiatry: 25 Trend Setters for 2013 - 3rd Biennial Report
• Novel therapeutics and future R&D
• 03 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities
• Alzheimers and Parkinsons Disease - Global Strategic Business Report